Induction Therapy With Cytarabine, High-Dose Mitoxantrone and Dasatinib for Patients With Philadelphia-Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia
 
Sponsors and Collaborators
Memorial Sloan-Kettering Cancer Center
Bristol-Myers Squibb
 
Contact
Nicole Lamanna, MD
212-639-2279
 
Peter Maslak, MD
212-639-5518
 
Investigator
Nicole Lamanna, MD
Memorial Sloan-Kettering Cancer Center
 
ClinicalTrials.gov Identifier